GSK2251052 in Complicated Urinary Tract Infection

NCT01381549 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
20
Enrollment
INDUSTRY
Sponsor class

Stopped Microbiological findings of resistance on therapy in patients with complicated urinary tract infection

Conditions

Interventions

Sponsor

GlaxoSmithKline